Heart Failure With Better Ejection Fraction A Modern Diagnosis

被引：21
作者：
Stevenson, Lynne Warner [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
CIRCULATION | 2014年 / 129卷 / 23期
关键词：
Editorials; cardiomyopathies; heart failure; stroke volume; MYOCARDIAL-INFARCTION; MORTALITY; SURVIVAL; MANAGEMENT; TRIAL; CARDIOMYOPATHY; ENALAPRIL; HYDRALAZINE; ASSOCIATION; DYSFUNCTION;
D O I：
10.1161/CIRCULATIONAHA.114.010194
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2364 / 2367
页数：4
相关论文
共 50 条
[41]   Pathophysiology of Heart Failure with Preserved Ejection Fraction [J].
Youn, Jong-Chan ;
Ahn, Yuran ;
Jung, Hae Ok .
HEART FAILURE CLINICS, 2021, 17 (03) :327-335
[42]   Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction [J].
Straw, Sam ;
McGinlay, Melanie ;
Witte, Klaus K. .
OPEN HEART, 2021, 8 (01)
[43]   Treatment of heart failure with a preserved ejection fraction [J].
Ahn, Yuran ;
Youn, Jong-Chan .
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (01) :18-25
[44]   Spironolactone for Heart Failure with Preserved Ejection Fraction [J].
Pitt, Bertram ;
Pfeffer, Marc A. ;
Assmann, Susan F. ;
Boineau, Robin ;
Anand, Inder S. ;
Claggett, Brian ;
Clausell, Nadine ;
Desai, Akshay S. ;
Diaz, Rafael ;
Fleg, Jerome L. ;
Gordeev, Ivan ;
Harty, Brian ;
Heitner, John F. ;
Kenwood, Christopher T. ;
Lewis, Eldrin F. ;
O'Meara, Eileen ;
Probstfield, Jeffrey L. ;
Shaburishvili, Tamaz ;
Shah, Sanjiv J. ;
Solomon, Scott D. ;
Sweitzer, Nancy K. ;
Yang, Song ;
McKinlay, Sonja M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15) :1383-1392
[45]   Comorbidities in heart failure with preserved ejection fraction [J].
Deichl, Andrea ;
Wachter, Rolf ;
Edelmann, Frank .
HERZ, 2022, 47 (04) :301-307
[46]   Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs [J].
Chen, Yei-Tsung ;
Wong, Lee Lee ;
Liew, Oi Wah ;
Richards, Arthur Mark .
CELLS, 2019, 8 (12)
[47]   Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-PRESERVE) [J].
Komajda, Michel ;
Carson, Peter E. ;
Hetzel, Scott ;
McKelvie, Robert ;
McMurray, John ;
Ptaszynska, Agata ;
Zile, Michael R. ;
DeMets, David ;
Massie, Barry M. .
CIRCULATION-HEART FAILURE, 2011, 4 (01) :27-U73
[48]   Left Ventricular Ejection Fraction as Criterion for Implantation of an Implantable Cardioverter-Defibrillator in Heart Failure Patients Undergoing Surgical Left Ventricular Reconstruction [J].
Mollema, Sjoerd A. ;
Klein, Patrick ;
Heersche, Jogien ;
Schalij, Martin J. ;
Van der Wall, Ernst E. ;
Versteegh, Michel I. M. ;
Klautz, Robert J. M. ;
Van Erven, Lieselot ;
Bax, Jeroen J. .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 (07) :913-917
[49]   Comparison of Perioperative Outcomes in Heart Failure Patients With Reduced Versus Preserved Ejection Fraction After Noncardiac Surgery [J].
Huang, Yolanda Ya-Chin ;
Chen, Ling ;
Wright, Jason D. .
ANNALS OF SURGERY, 2022, 275 (04) :807-815
[50]   Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction [J].
Stolfo, Davide ;
Sinagra, Gianfranco ;
Savarese, Gianluigi .
CARDIAC FAILURE REVIEW, 2022, 8
12345